Skip to main content
. 2017 May 22;9:161. doi: 10.3389/fnagi.2017.00161

Table 1.

Demographic and clinical characteristics of the participants in the seven VBM studies (eight data sets) included in the meta-analysis.

Study Patients with type 2 diabetes Healthy controls


No (% female) Mean age, year Education year Illness Duration, year BMI kg/m2 HbAlc% MMSE Comorbidity (number of patients) No (% female) Mean age, year Education year MRI Quality scores (out of 7)
Gold et al. 23 (52.2) 59.2 15.6 6 31.8 6.9 NA Dyslipidemia or hypertension 23 (52.2) 59.9 15.9 1.5T 12.5
Chen et al. 16 (52.2) 61.2 NA 13.2 25.7 8.4 26 Hypertension (6) 16 (52.2) 59.8 NA 3T 11.5
Moran et al. 350 (40.0) 67.8 11.3 7 31.1 7.2 NA Ischemic heart disease (82), TIA or stroke(37), hyperlipidemia (167) 363 (46.0) 72.1 10.9 1.5T 11
Garcia-Casares et al. 25 (32.0) 60.0 18.3 11.25 28.6 6.67 28.8 Hypertensive (11), dyslipidemia (11) 25 (44.0) 57.8 18.9 3T 12
Wang et al. 23 (30.4) 53.1 10.6 7 25.9 8.3 27.6 Hypertensive (10), dyslipidemia (8), lacunar infarcts(2) 23 (39.1) 53.9 10.7 3T 13
Zhang et al.a 25 (44.0) 52.2 12.9 6.44 24.29 7.39 27.84 NA 29 (58.6) 55.48 11.48 3T 12
Zhang et al.b 28 (71.4) 56.2 11.2 8.18 24.35 7.78 27.53 Mild cognitive impairment 29 (58.6) 55.48 11.48 3T 12
Ying et al. 40 (47.5) 60.5 10.0 8.90 24.4 7.7 28.3 Lacunar infarcts(9) 41 (68.3) 57.9 10.3 3T 12

BMI, body mass index; MMSE, Mini Mental State Examination; TIA, transient ischemic attack; aSubgroup of patients with type 2 diabetes but without mild cognitive impairment. bSubgroup of patients with type 2 diabetes and comorbid mild cognitive impairment.